AIM ImmunoTech Inc (AIM)
0.4176
0.00 (0.00%)
USD |
NYAM |
Apr 23, 16:00
0.4176
0.00 (0.00%)
After-Hours: 20:00
AIM ImmunoTech Total Long Term Debt (Quarterly): 0.00 for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.234M |
December 31, 2020 | 0.23M |
September 30, 2020 | 0.226M |
June 30, 2020 | 0.221M |
March 31, 2020 | 4.415M |
December 31, 2019 | 4.124M |
September 30, 2019 | 4.59M |
June 30, 2019 | 2.488M |
March 31, 2019 | 3.682M |
December 31, 2018 | 3.607M |
September 30, 2018 | 3.387M |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.222M |
December 31, 2017 | 1.835M |
Date | Value |
---|---|
September 30, 2017 | 1.466M |
June 30, 2017 | 0.517M |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 7.051M |
June 30, 2013 | 7.051M |
March 31, 2013 | 7.051M |
December 31, 2012 | 7.051M |
September 30, 2012 | 5.761M |
June 30, 2012 | 4.335M |
March 31, 2012 | 2.277M |
December 31, 2011 | 1.695M |
September 30, 2011 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2021
4.59M
Maximum
Sep 2019
0.8699M
Average
--
Median
Jun 2021
Total Long Term Debt (Quarterly) Benchmarks
Perspective Therapeutics Inc | 1.725M |
Protalix BioTherapeutics Inc | 20.25M |
Electromed Inc | 0.00 |
Xtant Medical Holdings Inc | 21.79M |
Armata Pharmaceuticals Inc | -- |